These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 15059806

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Induced cardiovascular procedural costs and resource consumption patterns after coronary artery calcium screening: results from the EISNER (Early Identification of Subclinical Atherosclerosis by Noninvasive Imaging Research) study.
    Shaw LJ, Min JK, Budoff M, Gransar H, Rozanski A, Hayes SW, Friedman JD, Miranda R, Wong ND, Berman DS.
    J Am Coll Cardiol; 2009 Sep 29; 54(14):1258-67. PubMed ID: 19778667
    [Abstract] [Full Text] [Related]

  • 23. Rates of progression of coronary calcium by electron beam tomography.
    Budoff MJ, Lane KL, Bakhsheshi H, Mao S, Grassmann BO, Friedman BC, Brundage BH.
    Am J Cardiol; 2000 Jul 01; 86(1):8-11. PubMed ID: 10867084
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Coronary artery calcium score improves cardiovascular risk prediction in persons without indication for statin therapy.
    Möhlenkamp S, Lehmann N, Greenland P, Moebus S, Kälsch H, Schmermund A, Dragano N, Stang A, Siegrist J, Mann K, Jöckel KH, Erbel R, Heinz Nixdorf Recall Study Investigators.
    Atherosclerosis; 2011 Mar 01; 215(1):229-36. PubMed ID: 21251655
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial.
    Schmermund A, Achenbach S, Budde T, Buziashvili Y, Förster A, Friedrich G, Henein M, Kerkhoff G, Knollmann F, Kukharchuk V, Lahiri A, Leischik R, Moshage W, Schartl M, Siffert W, Steinhagen-Thiessen E, Sinitsyn V, Vogt A, Wiedeking B, Erbel R.
    Circulation; 2006 Jan 24; 113(3):427-37. PubMed ID: 16415377
    [Abstract] [Full Text] [Related]

  • 28. Progression of coronary artery calcification in renal transplant recipients.
    Seyahi N, Cebi D, Altiparmak MR, Akman C, Ataman R, Pekmezci S, Serdengecti K.
    Nephrol Dial Transplant; 2012 May 24; 27(5):2101-7. PubMed ID: 21965591
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation.
    Achenbach S, Ropers D, Pohle K, Leber A, Thilo C, Knez A, Menendez T, Maeffert R, Kusus M, Regenfus M, Bickel A, Haberl R, Steinbeck G, Moshage W, Daniel WG.
    Circulation; 2002 Aug 27; 106(9):1077-82. PubMed ID: 12196332
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Coronary artery calcium score and coronary heart disease events in a large cohort of asymptomatic men and women.
    LaMonte MJ, FitzGerald SJ, Church TS, Barlow CE, Radford NB, Levine BD, Pippin JJ, Gibbons LW, Blair SN, Nichaman MZ.
    Am J Epidemiol; 2005 Sep 01; 162(5):421-9. PubMed ID: 16076829
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. C-reactive protein levels and outcomes after statin therapy.
    Ridker PM, Cannon CP, Morrow D, Rifai N, Rose LM, McCabe CH, Pfeffer MA, Braunwald E, Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators.
    N Engl J Med; 2005 Jan 06; 352(1):20-8. PubMed ID: 15635109
    [Abstract] [Full Text] [Related]

  • 39. Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy.
    Shishehbor MH, Aviles RJ, Brennan ML, Fu X, Goormastic M, Pearce GL, Gokce N, Keaney JF, Penn MS, Sprecher DL, Vita JA, Hazen SL.
    JAMA; 2003 Apr 02; 289(13):1675-80. PubMed ID: 12672736
    [Abstract] [Full Text] [Related]

  • 40. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
    Nicholls SJ, Tuzcu EM, Sipahi I, Grasso AW, Schoenhagen P, Hu T, Wolski K, Crowe T, Desai MY, Hazen SL, Kapadia SR, Nissen SE.
    JAMA; 2007 Feb 07; 297(5):499-508. PubMed ID: 17284700
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.